nodes	percent_of_prediction	percent_of_DWPC	metapath
Fospropofol—ALPL—Etoposide—Teniposide—lymphatic system cancer	0.158	0.783	CbGdCrCtD
Fospropofol—Hepatic insufficiency—Methotrexate—lymphatic system cancer	0.0732	0.0916	CcSEcCtD
Fospropofol—Hypoxia—Fludarabine—lymphatic system cancer	0.0601	0.0753	CcSEcCtD
Fospropofol—Hypoxemia—Methotrexate—lymphatic system cancer	0.0564	0.0706	CcSEcCtD
Fospropofol—ALPL—Gemcitabine—Cytarabine—lymphatic system cancer	0.0438	0.217	CbGdCrCtD
Fospropofol—Hepatic failure—Fludarabine—lymphatic system cancer	0.0308	0.0386	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.0218	0.0273	CcSEcCtD
Fospropofol—Skin disorder—Mechlorethamine—lymphatic system cancer	0.0204	0.0256	CcSEcCtD
Fospropofol—Hepatic failure—Vincristine—lymphatic system cancer	0.0188	0.0236	CcSEcCtD
Fospropofol—Hypoxia—Methotrexate—lymphatic system cancer	0.0178	0.0223	CcSEcCtD
Fospropofol—Pruritus—Mechlorethamine—lymphatic system cancer	0.0149	0.0186	CcSEcCtD
Fospropofol—Cough—Fludarabine—lymphatic system cancer	0.0146	0.0182	CcSEcCtD
Fospropofol—Hypotension—Teniposide—lymphatic system cancer	0.0145	0.0181	CcSEcCtD
Fospropofol—Vomiting—Mechlorethamine—lymphatic system cancer	0.0134	0.0167	CcSEcCtD
Fospropofol—Nervous system disorder—Fludarabine—lymphatic system cancer	0.0134	0.0167	CcSEcCtD
Fospropofol—Apnoea—Methotrexate—lymphatic system cancer	0.0134	0.0167	CcSEcCtD
Fospropofol—Nausea—Mechlorethamine—lymphatic system cancer	0.0125	0.0156	CcSEcCtD
Fospropofol—Paraesthesia—Fludarabine—lymphatic system cancer	0.0122	0.0153	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.0118	0.0147	CcSEcCtD
Fospropofol—Pain—Fludarabine—lymphatic system cancer	0.0116	0.0146	CcSEcCtD
Fospropofol—Pruritus—Teniposide—lymphatic system cancer	0.011	0.0137	CcSEcCtD
Fospropofol—Cough—Bleomycin—lymphatic system cancer	0.0107	0.0134	CcSEcCtD
Fospropofol—Angiopathy—Vincristine—lymphatic system cancer	0.0106	0.0133	CcSEcCtD
Fospropofol—Mediastinal disorder—Vincristine—lymphatic system cancer	0.0106	0.0132	CcSEcCtD
Fospropofol—Vomiting—Teniposide—lymphatic system cancer	0.00986	0.0123	CcSEcCtD
Fospropofol—Headache—Teniposide—lymphatic system cancer	0.00971	0.0122	CcSEcCtD
Fospropofol—Pruritus—Fludarabine—lymphatic system cancer	0.00964	0.0121	CcSEcCtD
Fospropofol—Hypotension—Bleomycin—lymphatic system cancer	0.00933	0.0117	CcSEcCtD
Fospropofol—Nausea—Teniposide—lymphatic system cancer	0.00921	0.0115	CcSEcCtD
Fospropofol—Hepatic failure—Methotrexate—lymphatic system cancer	0.00914	0.0115	CcSEcCtD
Fospropofol—Paraesthesia—Bleomycin—lymphatic system cancer	0.00897	0.0112	CcSEcCtD
Fospropofol—Cough—Mitoxantrone—lymphatic system cancer	0.00867	0.0109	CcSEcCtD
Fospropofol—Vomiting—Fludarabine—lymphatic system cancer	0.00866	0.0108	CcSEcCtD
Fospropofol—Pain—Bleomycin—lymphatic system cancer	0.00854	0.0107	CcSEcCtD
Fospropofol—Headache—Fludarabine—lymphatic system cancer	0.00853	0.0107	CcSEcCtD
Fospropofol—Nervous system disorder—Vincristine—lymphatic system cancer	0.00816	0.0102	CcSEcCtD
Fospropofol—Hypotension—Carmustine—lymphatic system cancer	0.00815	0.0102	CcSEcCtD
Fospropofol—Nausea—Fludarabine—lymphatic system cancer	0.00809	0.0101	CcSEcCtD
Fospropofol—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00787	0.00986	CcSEcCtD
Fospropofol—Paraesthesia—Carmustine—lymphatic system cancer	0.00783	0.00981	CcSEcCtD
Fospropofol—Hypotension—Vincristine—lymphatic system cancer	0.00778	0.00974	CcSEcCtD
Fospropofol—Hypotension—Mitoxantrone—lymphatic system cancer	0.00757	0.00949	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00753	0.00943	CcSEcCtD
Fospropofol—Paraesthesia—Vincristine—lymphatic system cancer	0.00747	0.00936	CcSEcCtD
Fospropofol—Pain—Carmustine—lymphatic system cancer	0.00746	0.00934	CcSEcCtD
Fospropofol—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00728	0.00912	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00719	0.009	CcSEcCtD
Fospropofol—Pain—Vincristine—lymphatic system cancer	0.00712	0.00891	CcSEcCtD
Fospropofol—Pruritus—Bleomycin—lymphatic system cancer	0.00707	0.00885	CcSEcCtD
Fospropofol—Pain—Mitoxantrone—lymphatic system cancer	0.00693	0.00868	CcSEcCtD
Fospropofol—Vomiting—Bleomycin—lymphatic system cancer	0.00635	0.00795	CcSEcCtD
Fospropofol—Nausea—Bleomycin—lymphatic system cancer	0.00593	0.00743	CcSEcCtD
Fospropofol—Vomiting—Carmustine—lymphatic system cancer	0.00554	0.00694	CcSEcCtD
Fospropofol—Headache—Carmustine—lymphatic system cancer	0.00546	0.00684	CcSEcCtD
Fospropofol—Vomiting—Vincristine—lymphatic system cancer	0.00529	0.00663	CcSEcCtD
Fospropofol—Headache—Vincristine—lymphatic system cancer	0.00521	0.00653	CcSEcCtD
Fospropofol—Nausea—Carmustine—lymphatic system cancer	0.00518	0.00649	CcSEcCtD
Fospropofol—Angiopathy—Methotrexate—lymphatic system cancer	0.00516	0.00646	CcSEcCtD
Fospropofol—Vomiting—Mitoxantrone—lymphatic system cancer	0.00515	0.00645	CcSEcCtD
Fospropofol—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.00512	0.00642	CcSEcCtD
Fospropofol—Headache—Mitoxantrone—lymphatic system cancer	0.00508	0.00636	CcSEcCtD
Fospropofol—Nausea—Vincristine—lymphatic system cancer	0.00494	0.00619	CcSEcCtD
Fospropofol—Nausea—Mitoxantrone—lymphatic system cancer	0.00481	0.00603	CcSEcCtD
Fospropofol—Cough—Methotrexate—lymphatic system cancer	0.00432	0.00541	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.00418	0.00524	CcSEcCtD
Fospropofol—Nervous system disorder—Methotrexate—lymphatic system cancer	0.00396	0.00496	CcSEcCtD
Fospropofol—Skin disorder—Methotrexate—lymphatic system cancer	0.00392	0.00491	CcSEcCtD
Fospropofol—Hypotension—Methotrexate—lymphatic system cancer	0.00377	0.00473	CcSEcCtD
Fospropofol—Paraesthesia—Methotrexate—lymphatic system cancer	0.00363	0.00454	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.00349	0.00437	CcSEcCtD
Fospropofol—Pain—Methotrexate—lymphatic system cancer	0.00345	0.00433	CcSEcCtD
Fospropofol—Pruritus—Methotrexate—lymphatic system cancer	0.00286	0.00358	CcSEcCtD
Fospropofol—Vomiting—Methotrexate—lymphatic system cancer	0.00257	0.00322	CcSEcCtD
Fospropofol—Headache—Methotrexate—lymphatic system cancer	0.00253	0.00317	CcSEcCtD
Fospropofol—Nausea—Methotrexate—lymphatic system cancer	0.0024	0.003	CcSEcCtD
